- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04105842
Refitting Daily Disposable Contact Lens Wearers With Dry Eye Disease With A Different Daily Disposable Lens Type (CORGI)
July 13, 2023 updated by: University of Waterloo
The purpose of this study is to refit habitual wearers of daily disposable contact lenses who currently experience symptoms of dry eye and discomfort during lens wear with a different type of daily disposable contact lens.
Ocular signs and symptoms of dry eye will be assessed following the guidelines outlined by the Tear Film and Ocular Surface Society (TFOS) in the Dry Eye Workshop II (DEWS II).
The performance of the habitual contact lenses and the study lenses will be determined using different optometric assessments.
Study lenses will be worn for one month following a daily disposable wear schedule.
Study Overview
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Waterloo, Ontario, Canada, N2B 3K4
- Centre for Ocular Research & Education
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
17 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Is at least 17 years of age and has full legal capacity to volunteer;
- Has read and signed an information consent letter;
- Is willing and able to follow instructions and maintain the appointment schedule;
As per TFOS DEWS II, have dry eye symptoms (without CL wear) as determined by an OSDI score of ≥13 and at least one of the following:
- Tear osmolarity ≥ 308mOsm/L or interocular difference >8 mOsm/L
- Non-invasive tear breakup time of < 10 seconds in at least one eye
- More than 5 spots of corneal staining OR > 9 conjunctival spots in at least one eye
- Reports dryness while wearing DD CLs with CLDEQ-8 score ≥ 12 and ≤ 203
- Habitually wears soft spherical DD CLs with a power between +6.00D and -10.00D
- Manifest spectacle cyl ≤1.00DC in either eye
- BCVA ≤0.20 log MAR each eye with habitual & DT1
- Acceptable fit with habitual & DT1
- Willing to wear DT1 CLs at least 3 days per week and 6 hours per day throughout the study
Exclusion Criteria:
- Is participating in any concurrent clinical or research study;
- Has any known active* ocular disease and/or infection;
- Has a systemic condition that in the opinion of the investigator may affect a study outcome variable;
- Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable;
- Has known sensitivity to the diagnostic pharmaceuticals to be used in the study;
- Is pregnant, lactating or planning a pregnancy at the time of enrolment (by self-report);
- Is aphakic;
- Has undergone refractive error surgery;
- Has taken part in another clinical research study within the last 14 days;
- Current habitual wearer of DT1
Any ocular and/or systemic conditions or concomitant medication to contraindicate contact lens wear or be expected to interfere with the primary outcome variables.
- For the purposes of this study, active ocular disease is defined as infection or inflammation which requires therapeutic treatment. Mild (i.e. not considered clinically relevant) lid abnormalities (blepharitis, meibomian gland dysfunction, papillae), corneal and conjunctival staining and dry eye are not considered active ocular disease. Neovascularization and corneal scars are the result of previous hypoxia, infection or inflammation and are therefore not active.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Delfilcon A
All study participants will be refit with Delfilcon A (Dailies Total 1) lenses which they will wear for 1 month.
|
Participants wear delafilcon A contact lenses on a daily disposable basis.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subjective Comfort at End of Day With Contact Lens Wear
Time Frame: Day 1 after screening with habitual lenses
|
Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best).
|
Day 1 after screening with habitual lenses
|
|
Subjective Comfort at End of Day With Contact Lens Wear
Time Frame: Day 3 after screening with habitual lenses
|
Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best).
|
Day 3 after screening with habitual lenses
|
|
Subjective Comfort at End of Day With Contact Lens Wear
Time Frame: Day 5 after screening with habitual lenses
|
Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best).
|
Day 5 after screening with habitual lenses
|
|
Subjective Comfort at End of Day With Contact Lens Wear
Time Frame: 1-week follow up with habitual lens
|
Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best).
|
1-week follow up with habitual lens
|
|
Subjective Comfort at End of Day With Contact Lens Wear
Time Frame: Day 1 after dispense with delefilcon A
|
Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best).
|
Day 1 after dispense with delefilcon A
|
|
Subjective Comfort at End of Day With Contact Lens Wear
Time Frame: Day 3 after dispense with delefilcon A
|
Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best).
|
Day 3 after dispense with delefilcon A
|
|
Subjective Comfort at End of Day With Contact Lens Wear
Time Frame: Day 5 after dispense with delefilcon A
|
Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best).
|
Day 5 after dispense with delefilcon A
|
|
Subjective Comfort at End of Day With Contact Lens Wear
Time Frame: Day 7 after dispense with delefilcon A
|
Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best).
|
Day 7 after dispense with delefilcon A
|
|
Subjective Comfort at End of Day With Contact Lens Wear
Time Frame: Day 21 after dispense with delefilcon A
|
Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best).
|
Day 21 after dispense with delefilcon A
|
|
Subjective Comfort at End of Day With Contact Lens Wear
Time Frame: Day 28 after dispense with delefilcon A
|
Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best).
|
Day 28 after dispense with delefilcon A
|
|
Subjective Comfort at End of Day With Contact Lens Wear
Time Frame: 1-month follow up with delefilcon A
|
Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best).
|
1-month follow up with delefilcon A
|
|
Subjective Rating of End of Day Dryness With Contact Lens Wear
Time Frame: Day 1 after screening with habitual lenses
|
Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best).
|
Day 1 after screening with habitual lenses
|
|
Subjective Rating of End of Day Dryness With Contact Lens Wear
Time Frame: Day 3 after screening with habitual lenses
|
Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best).
|
Day 3 after screening with habitual lenses
|
|
Subjective Rating of End of Day Dryness With Contact Lens Wear
Time Frame: Day 5 after screening with habitual lenses
|
Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best).
|
Day 5 after screening with habitual lenses
|
|
Subjective Rating of End of Day Dryness With Contact Lens Wear
Time Frame: 1-week follow up with habitual lens
|
Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best).
|
1-week follow up with habitual lens
|
|
Subjective Rating of End of Day Dryness With Contact Lens Wear
Time Frame: Day 1 after dispense with delefilcon A
|
Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best).
|
Day 1 after dispense with delefilcon A
|
|
Subjective Rating of End of Day Dryness With Contact Lens Wear
Time Frame: Day 3 after dispense with delefilcon A
|
Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best).
|
Day 3 after dispense with delefilcon A
|
|
Subjective Rating of End of Day Dryness With Contact Lens Wear
Time Frame: Day 5 after dispense with delefilcon A
|
Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best).
|
Day 5 after dispense with delefilcon A
|
|
Subjective Rating of End of Day Dryness With Contact Lens Wear
Time Frame: Day 7 after dispense with delefilcon A
|
Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best).
|
Day 7 after dispense with delefilcon A
|
|
Subjective Rating of End of Day Dryness With Contact Lens Wear
Time Frame: Day 21 after dispense with delefilcon A
|
Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best).
|
Day 21 after dispense with delefilcon A
|
|
Subjective Rating of End of Day Dryness With Contact Lens Wear
Time Frame: Day 28 after dispense with delefilcon A
|
Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best).
|
Day 28 after dispense with delefilcon A
|
|
Subjective Rating of End of Day Dryness With Contact Lens Wear
Time Frame: 1-month follow up with delefilcon A
|
Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best).
|
1-month follow up with delefilcon A
|
|
Average Lens Wear Time
Time Frame: Day 1 after screening with habitual lenses
|
Average lens wear time is recorded
|
Day 1 after screening with habitual lenses
|
|
Average Lens Wear Time
Time Frame: Day 3 after screening with habitual lenses
|
Average lens wear time is recorded
|
Day 3 after screening with habitual lenses
|
|
Average Lens Wear Time
Time Frame: Day 5 after screening with habitual lenses
|
Average lens wear time is recorded
|
Day 5 after screening with habitual lenses
|
|
Average Lens Wear Time
Time Frame: 1-week follow up with habitual lens
|
Average lens wear time is recorded
|
1-week follow up with habitual lens
|
|
Average Lens Wear Time
Time Frame: Day 1 after dispense with delefilcon A
|
Average lens wear time is recorded
|
Day 1 after dispense with delefilcon A
|
|
Average Lens Wear Time
Time Frame: Day 3 after dispense with delefilcon A
|
Average lens wear time is recorded
|
Day 3 after dispense with delefilcon A
|
|
Average Lens Wear Time
Time Frame: Day 5 after dispense with delefilcon A
|
Average lens wear time is recorded
|
Day 5 after dispense with delefilcon A
|
|
Average Lens Wear Time
Time Frame: Day 7 after dispense with delefilcon A
|
Average lens wear time is recorded
|
Day 7 after dispense with delefilcon A
|
|
Average Lens Wear Time
Time Frame: Day 21 after dispense with delefilcon A
|
Average lens wear time is recorded
|
Day 21 after dispense with delefilcon A
|
|
Average Lens Wear Time
Time Frame: Day 28 after dispense with delefilcon A
|
Average lens wear time is recorded
|
Day 28 after dispense with delefilcon A
|
|
Average Lens Wear Time
Time Frame: 1-month follow up with delefilcon A
|
Average lens wear time is recorded
|
1-month follow up with delefilcon A
|
|
Comfortable Lens Wear Time
Time Frame: Day 1 after screening with habitual lenses
|
Comfortable lens wear time (Time of discomfort - Time of insertion)
|
Day 1 after screening with habitual lenses
|
|
Comfortable Lens Wear Time
Time Frame: Day 3 after screening with habitual lenses
|
Comfortable lens wear time (Time of discomfort - Time of insertion)
|
Day 3 after screening with habitual lenses
|
|
Comfortable Lens Wear Time
Time Frame: Day 5 after screening with habitual lenses
|
Comfortable lens wear time (Time of discomfort - Time of insertion)
|
Day 5 after screening with habitual lenses
|
|
Comfortable Lens Wear Time
Time Frame: 1-week follow up with habitual lens
|
Comfortable lens wear time (Time of discomfort - Time of insertion)
|
1-week follow up with habitual lens
|
|
Comfortable Lens Wear Time
Time Frame: Day 1 after dispense with delefilcon A
|
Comfortable lens wear time (Time of discomfort - Time of insertion)
|
Day 1 after dispense with delefilcon A
|
|
Comfortable Lens Wear Time
Time Frame: Day 3 after dispense with delefilcon A
|
Comfortable lens wear time (Time of discomfort - Time of insertion)
|
Day 3 after dispense with delefilcon A
|
|
Comfortable Lens Wear Time
Time Frame: Day 5 after dispense with delefilcon A
|
Comfortable lens wear time (Time of discomfort - Time of insertion)
|
Day 5 after dispense with delefilcon A
|
|
Comfortable Lens Wear Time
Time Frame: Day 7 after dispense with delefilcon A
|
Comfortable lens wear time (Time of discomfort - Time of insertion)
|
Day 7 after dispense with delefilcon A
|
|
Comfortable Lens Wear Time
Time Frame: Day 21 after dispense with delefilcon A
|
Comfortable lens wear time (Time of discomfort - Time of insertion)
|
Day 21 after dispense with delefilcon A
|
|
Comfortable Lens Wear Time
Time Frame: Day 28 after dispense with delefilcon A
|
Comfortable lens wear time (Time of discomfort - Time of insertion)
|
Day 28 after dispense with delefilcon A
|
|
Comfortable Lens Wear Time
Time Frame: 1-month follow up with delefilcon A
|
Comfortable lens wear time (Time of discomfort - Time of insertion)
|
1-month follow up with delefilcon A
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Lyndon Jones, PhD, FCOptom, Centre for Ocular Research & Education
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 23, 2019
Primary Completion (Actual)
July 28, 2022
Study Completion (Actual)
July 28, 2022
Study Registration Dates
First Submitted
September 13, 2019
First Submitted That Met QC Criteria
September 25, 2019
First Posted (Actual)
September 26, 2019
Study Record Updates
Last Update Posted (Actual)
July 25, 2023
Last Update Submitted That Met QC Criteria
July 13, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 41251
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dry Eye
-
Universiti Sains MalaysiaNot yet recruitingDry Eye Disease (DED) | Dry Eye Symptoms | Dry Eye Syndrome (DES)Malaysia
-
Southern College of OptometryNot yet recruitingEye Diseases | Dry Eye | Chronic Dry Eye
-
The University of New South WalesUniversity of MelbourneRecruitingDry Eye Disease (DED)Australia
-
Southern College of OptometryNot yet recruitingEye Diseases | Dry Eye | Dry Eye Syndromes | Dry Eyes Chronic
-
Singapore National Eye CentreThe Eye Hospital of Wenzhou Medical UniversityNot yet recruiting
-
The Hong Kong Polytechnic UniversityRecruitingDry Eye | Dry Eye Disease (DED)Hong Kong
-
University of MiamiNot yet recruitingEye Diseases | Dry Eye | Eyes Dry ChronicUnited States
-
BioTissue Holdings, IncCompletedDry Eye | Dry Eye Disease (DED) | Dry Eye Disease With Severe KeratitisUnited States
-
Southern College of OptometryRecruitingEye Diseases | Dry Eye | Eyes Dry ChronicUnited States
-
Laboratoires TheaRecruitingDry Eye Disease (DED)Bulgaria
Clinical Trials on Delfilcon A
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedCorneal Infiltrative Events | Corneal InflammationUnited States
-
CooperVision International Limited (CVIL)Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
CooperVision, Inc.Completed
-
Bausch & Lomb IncorporatedCompleted
-
Johnson & Johnson Vision Care, Inc.Completed
-
CooperVision International Limited (CVIL)University of California, BerkeleyRecruiting
-
CooperVision, Inc.CompletedPresbyopia | AstigmatismUnited Kingdom